39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
20 °P sammeln
  • Broschiertes Buch

Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln…mehr

Produktbeschreibung
Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln this book, we review A novel synthesis-therapy in nanoscale for asthma patients by inhibits phosphodiesterase enzyme.
Autorenporträt
Zainab Sabri Abbas: I am a researcher in the field of Nano-Biochemistry. I completed my bachelor's degree at the Wasit University -Department of Chemistry in 2017, after which I completed my master's degree at Al-Mustansiriya University -Department of Chemistry in 2020. I have 8 Manuscripts and two patents in the nanochemistry field (December 2020)